Type II Diabetes
Conditions
Keywords
Type II Diabetes, Personalized Health Planning, Shared Medical Appointments
Brief summary
The primary aim of this study is to examine the feasibility of implementing an evidence based patient engagement strategy, known as personalized health planning (PHP), in the context of a a shared medical appointment (SMA) for individuals with type II diabetes in a primary care setting.
Detailed description
All data for the prospective portion of this study was done being collected in September 2016. The retrospective chart review will collect data up until March of 2017 (six months after the last subject completed the prospective phase by attending their last SMA session).
Interventions
BEHAVIORALPersonalized Health Planning Shared Medical Appointment
The PHP SMA group will combine personalized health planning with a modified version of the standard shared diabetes medical appointment. Modifications include: a self-assessment of health status, greater emphasis on a collaborative patient-provider health goal-setting process, a plan to meet goals, a mindfulness practice included in each session, and the creation of a 'personalized health plan' participant notebook for each individual to document health goals and track progress to review at each session. The participant notebook also includes educational handouts and worksheets to complement the educational curriculum
Sponsors
Duke University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* A diagnosis of Type 2 diabetes within the last year * A current patient at Duke Family Medicine. * An A1C score greater than 7 and less than 14.
Exclusion criteria
* A diagnosis of Pre-diabetes * A diagnosis of Type I diabetes * Individuals with amputations as a result of their diabetes are excluded form this study. * Individuals with renal dialysis will not be included in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feasibility measured using a patient satisfaction survey | 12 months |
| Change in patient activation measured using the patient activation measure | baseline; 6 months; 12 months |
| Change in self-management of diabetes self-efficacy using the Diabetes Empowerment Scale | baseline; 6 months; 12 months |
| Change in diabetes self efficacy using the 1-item diabetes self-efficacy scale | baseline; 6 months; 12 months |
| Change in A1C using the A1C blood test | baseline; 3 months; 6 months; 9 months; 12 months |
Secondary
| Measure | Time frame |
|---|---|
| change in blood pressure using blood pressure measurement | baseline; 1 months; 2 months; 3 months; 5 months; 8 months; 10 months; 12 months |
| Change in depression screening score using the Patient Health Questionnaire (PHQ-9) | baseline; 6 months; 12 months |
| Change in low-density lipoprotein cholesterol (LDL) using LDL measurement | baseline; 6 months; 12 months |
| Change in functional health and well-being using the short form health survey | baseline; 6 months; 12 months |
| Change in general self-rated health using the general self rated health survey (GSRH) | baseline; 6 months; 12 months |
| Change in health goal progress using a goal progress visual analog scale | 3 months; 10 months |
| change in body mass index using weight and height measurements | baseline; 1 months; 2 months; 3 months; 5 months; 8 months; 10 months; 12 months |
Countries
United States
Outcome results
None listed